Decheng Capital Management III (Cayman) LLC 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 11:56 am Purchase | 2021-12-31 | 13G | Checkmate Pharmaceuticals, Inc. CMPI | Decheng Capital Management III (Cayman) LLC | 1,333,254 6.160% | 1,333,254 (New Position) | Filing |